http://www.fpnotebook.com/
Olanzapine
Aka: Olanzapine, Zyprexa
- Class
- Atypical Antipsychotic (Second Generation agent)
- Neuroleptic
- Thienobenzodiazepine
- Indications
- Schizophrenia
- Acute mania phase of Bipolar Disorder
- No longer recommended for Psychosis in Dementia
- Higher risk of CVA and overall mortality in elderly
- Dosing
- Adults
- Start: 5 to 10 mg PO qd
- Increase in 5 mg increments weekly as tolerated
- Maximum: 20 mg/day
- Elderly
- Initial: 1.25 to 2.5 mg PO qd
- Titrate up as tolerated (watch for Hypotension)
- Maximum: 10 mg/day
- Adverse effects
- Weight gain (4 kg)
- Sedation
- Orthostatic Hypotension
- Seizures (nearly 1% of patients)
- Overall higher mortality in elderly
- Hyperglycemia
- Increased risk of Diabetes Mellitus
- Koro (2002) BMJ 325:243-5
- Hyperlipidemia
- Koro (2002) Arch Gen Psychiatry 59:1021-6
- Drug Interactions
- Increase Antipsychotic levels (toxicity risk): Monitor for toxicity
- Ciprofloxacin
- Fluvoxamine
- Decrease Antipsychotic levels (lower efficacy)
- Carbamazepine
- Phenytoin
- Nicotine
- Rifampin
- Omeprazole
- Monitoring
- See Antipsychotic